. Author manuscript; available in PMC: 2016 Nov 10.

Published in final edited form as: J Control Release. 2015 Sep 11;217:191–201. doi: 10.1016/j.jconrel.2015.09.005

Table 1.

Peptide sequences utilized. Standard amino acid abbreviations are used. ↓ indicates MMP cleavage site.

Peptide Sequence	Origin/Notes	Peptide Nickname
TLEGTKKGHKLHLDY	Basic region of SPARC [16–18]	SPARC₁₁₃
KKGHK	Cu²⁺ binding region of SPARC [16–18]	SPARC₁₁₈
GLKEQSPRKHRLG	Scrambled control peptide [15]	Scrambled

peptide drug-G	No additional Gly added to C-termini of Scrambled	“N” form
LRAG-peptide drug-IPES-G	No additional Gly added to N-termini of Scrambled	“2T” form
C-IPES↓LRAG-peptide drug-IPES↓LRAG-C-G	No additional Gly added to N-termini of Scrambled	“DL” form

C-KGKGKGKGK-C-G	Non-degradable crosslinker	NDL

CG-RGDS-G	Cell adhesion peptide	RGD

Texas Red-GGEGGEGC-G	Fluorescently labeled peptide	FLP*